Covered recipient · General Payments record
ROCHELLE ROBICHEAUX METOYER
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,277.69
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $682.38 | 32 |
| Education | $113.96 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $168.31 | 10 |
| GENZYME CORPORATION | $124.99 | 1 |
| Janssen Biotech, Inc. | $114.89 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $86.65 | 4 |
| PFIZER INC. | $77.43 | 4 |
| ABBVIE INC. | $58.87 | 3 |
| Sandoz Inc. | $41.41 | 2 |
| Merck Sharp & Dohme Corporation | $28.51 | 2 |
| Organon LLC | $25.79 | 2 |
| Aurinia Pharma U.S., Inc. | $18.79 | 1 |
| UCB, Inc. | $18.61 | 1 |
| Exact Sciences Corporation | $17.13 | 1 |
| Celltrion USA Inc. | $14.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.00 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105958852 | CMS |
| ABBVIE INC. | $18.50 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105958854 | CMS |
| ABBVIE INC. | $24.37 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105958856 | CMS |
| Amgen Inc. | $2.33 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061753 | CMS |
| Amgen Inc. | $15.74 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061785 | CMS |
| Amgen Inc. | $4.66 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061793 | CMS |
| Amgen Inc. | $17.24 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061799 | CMS |
| Amgen Inc. | $16.01 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061805 | CMS |
| Amgen Inc. | $28.01 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117667951 | CMS |
| Amgen Inc. | $17.56 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061759 | CMS |
| Amgen Inc. | $21.91 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061779 | CMS |
| Amgen Inc. | $22.23 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061766 | CMS |
| Amgen Inc. | $22.62 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061773 | CMS |
| Aurinia Pharma U.S., Inc. | $18.79 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150690742 | CMS |
| Celltrion USA Inc. | $14.96 | 01/09/2024 | Education | Undisputed | 01/23/2026 | 1075857327 | CMS |
| Exact Sciences Corporation | $17.13 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114857144 | CMS |
| GENZYME CORPORATION | $124.99 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139935775 | CMS |
| Janssen Biotech, Inc. | $15.89 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078682014 | CMS |
| Janssen Biotech, Inc. | $99.00 | 06/24/2024 | Education | Undisputed | 01/23/2026 | 1078681933 | CMS |
| Merck Sharp & Dohme LLC | $15.00 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141966347 | CMS |
| Merck Sharp & Dohme LLC | $13.51 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141674901 | CMS |
| Novartis Pharmaceuticals Corporation | $23.89 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087259441 | CMS |
| Novartis Pharmaceuticals Corporation | $16.48 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087259453 | CMS |
| Novartis Pharmaceuticals Corporation | $24.93 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087259457 | CMS |
| Novartis Pharmaceuticals Corporation | $21.35 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087259463 | CMS |
| Organon Llc | $6.68 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136286399 | CMS |
| Organon Llc | $19.11 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136286403 | CMS |
| PFIZER INC. | $22.44 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131066346 | CMS |
| PFIZER INC. | $13.65 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131080637 | CMS |
| PFIZER INC. | $19.36 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131285446 | CMS |
| PFIZER INC. | $21.98 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132130058 | CMS |
| Sandoz Inc. | $19.66 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089373727 | CMS |
| Sandoz Inc. | $21.75 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089373769 | CMS |
| UCB, Inc. | $18.61 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143016594 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.